Global Expansion MedPharm is expanding capacity with a new 110,000 sq ft facility in Durham, NC, and operates in the US, UK, with a transatlantic partnership with Purna Pharmaceuticals in Belgium. This indicates capacity to take on larger, cross-border development and manufacturing programs for global sponsors.

Transatlantic Partnership New collaboration with Purna Pharmaceuticals NV broadens geographic reach and, combined with MedPharm’s integrated topical and epithelial delivery expertise, offers joint development and manufacturing solutions for sponsors seeking cross-continental clinical and commercial supply.

Specialized Delivery MedPharm’s focus on topical and transepithelial products across skin, nail, eye, nasal & pulmonary, mucosal, and other delivery routes positions them as a compelling partner for sponsors with dermatology, ophthalmology, and mucosal therapy programs seeking specialized formulation development and device integration.

Integrated Toolbox Proprietary predictive, human-relevant preclinical models enable early, data-rich decisions on formulation performance and PK/PD, reducing risk and accelerating timelines for early-stage sponsors who require solid go/no-go milestones before Clinical Trial material manufacturing.

Executive & Capabilities Recent leadership and analytical suite expansions in the US, plus a broad service slate (formulation, analytical, IVRT/IVPT, device & combination products, stability, and GMP manufacturing) create a one-stop shop for sponsors seeking rapid scale-up from concept to Commercial GMP production.